Exploring the Therapeutic Potential of Lawsone and Nanoparticles in Cancer and Infectious Disease Management
Lawsone, a naturally occurring compound found in henna, has been used in traditional medicine for centuries due to its diverse biological activities. In recent years, its nanoparticle‐based structure has gained attention in cancer and infectious disease research. This review explores the therapeutic...
Saved in:
Published in | Chemistry & biodiversity Vol. 21; no. 4; pp. e202301777 - n/a |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Wiley Subscription Services, Inc
01.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Lawsone, a naturally occurring compound found in henna, has been used in traditional medicine for centuries due to its diverse biological activities. In recent years, its nanoparticle‐based structure has gained attention in cancer and infectious disease research. This review explores the therapeutic potential of lawsone and its nanoparticles in the context of cancer and infectious diseases. Lawsone exhibits promising anticancer properties by inducing apoptosis and inhibiting cell proliferation, while its nanoparticle formulations enhance targeted delivery and efficacy. Moreover, lawsone demonstrates significant antimicrobial effects against various pathogens. The unique physicochemical properties of lawsone nanoparticles enable efficient cellular uptake and targeted delivery. Potential applications in combination therapy and personalized medicine open new avenues for cancer and infectious disease treatment. While clinical trials are needed to validate their safety and efficacy, lawsone‐based nanoparticles offer hope in addressing unmet medical needs and revolutionizing therapeutic approaches. |
---|---|
AbstractList | Lawsone, a naturally occurring compound found in henna, has been used in traditional medicine for centuries due to its diverse biological activities. In recent years, its nanoparticle-based structure has gained attention in cancer and infectious disease research. This review explores the therapeutic potential of lawsone and its nanoparticles in the context of cancer and infectious diseases. Lawsone exhibits promising anticancer properties by inducing apoptosis and inhibiting cell proliferation, while its nanoparticle formulations enhance targeted delivery and efficacy. Moreover, lawsone demonstrates significant antimicrobial effects against various pathogens. The unique physicochemical properties of lawsone nanoparticles enable efficient cellular uptake and targeted delivery. Potential applications in combination therapy and personalized medicine open new avenues for cancer and infectious disease treatment. While clinical trials are needed to validate their safety and efficacy, lawsone-based nanoparticles offer hope in addressing unmet medical needs and revolutionizing therapeutic approaches. Abstract Lawsone, a naturally occurring compound found in henna, has been used in traditional medicine for centuries due to its diverse biological activities. In recent years, its nanoparticle‐based structure has gained attention in cancer and infectious disease research. This review explores the therapeutic potential of lawsone and its nanoparticles in the context of cancer and infectious diseases. Lawsone exhibits promising anticancer properties by inducing apoptosis and inhibiting cell proliferation, while its nanoparticle formulations enhance targeted delivery and efficacy. Moreover, lawsone demonstrates significant antimicrobial effects against various pathogens. The unique physicochemical properties of lawsone nanoparticles enable efficient cellular uptake and targeted delivery. Potential applications in combination therapy and personalized medicine open new avenues for cancer and infectious disease treatment. While clinical trials are needed to validate their safety and efficacy, lawsone‐based nanoparticles offer hope in addressing unmet medical needs and revolutionizing therapeutic approaches. |
Author | Abed Hussein, Shaymaa Alawadi, Ahmed Hussien Ramadan, Montather F. Al‐dolaimy, F. Otbah Farqad, Rand Hamood, Sarah A. Thabit, Daha Alsaalamy, Ali Jasim Al‐Khafaji, Hanadi Had Talib Kareem, Ashwaq Kamil Zaidan, Haider |
Author_xml | – sequence: 1 givenname: Haider surname: Kamil Zaidan fullname: Kamil Zaidan, Haider organization: Al-Mustaqbal University – sequence: 2 givenname: Hanadi Had surname: Jasim Al‐Khafaji fullname: Jasim Al‐Khafaji, Hanadi Had organization: The University of Jordan – sequence: 3 givenname: F. surname: Al‐dolaimy fullname: Al‐dolaimy, F. organization: Al-Zahraa University for Women – sequence: 4 givenname: Shaymaa surname: Abed Hussein fullname: Abed Hussein, Shaymaa organization: Al-Manara College for Medical Sciences – sequence: 5 givenname: Rand surname: Otbah Farqad fullname: Otbah Farqad, Rand organization: Al-Noor University College – sequence: 6 givenname: Daha surname: Thabit fullname: Thabit, Daha organization: Al-Farahidi University – sequence: 7 givenname: Ashwaq surname: Talib Kareem fullname: Talib Kareem, Ashwaq organization: National University of Science and Technology – sequence: 8 givenname: Montather F. surname: Ramadan fullname: Ramadan, Montather F. organization: Al-Ayen University – sequence: 9 givenname: Sarah A. surname: Hamood fullname: Hamood, Sarah A. organization: Al-Esraa University College – sequence: 10 givenname: Ahmed Hussien surname: Alawadi fullname: Alawadi, Ahmed Hussien organization: The Islamic University of Babylon – sequence: 11 givenname: Ali surname: Alsaalamy fullname: Alsaalamy, Ali email: alihashimalsalamy78@gmail.com, alialisha787i@gmail.com organization: Imam Ja'afar Al-Sadiq University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38373183$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUlvFDEQhS0URBa4ckSWuHCZiZduL0eYJBBpWA6Bq1VxVyeOeuzG7ibJv8dhkkHiwskl-6tXz_UOyV5MEQl5zdmSMyaO_WX3aymYkIxrrZ-RA664WHBj2N6u1mKfHJZyU_l6b16QfWmkltzIAzKc3o1DyiFe0eka6cU1ZhhxnoKn39KEcQow0NTTNdyWOplC7OgXiGmEXJkBCw2RriB6zH_ezmOPfgppLvQkFISC9DNEuMJN1XpJnvcwFHz1eB6R72enF6tPi_XXj-er9-uFr7b0QskGbS-sbIVH3rZd1_QcOm0aa6xqTQOe1_8CqIp3wjZM-Z6rFpRGhqaXR-TdVnfM6eeMZXKbUDwOA0SszpywdRGtapSq6Nt_0Js051jdOcmkVdoaJiu13FI-p1Iy9m7MYQP53nHmHnJwDzm4XQ614c2j7Hy5wW6HPy2-AnYL3IYB7_8j51YfTn78Ff8N8F2Vmg |
CitedBy_id | crossref_primary_10_1002_cbdv_202400366 |
Cites_doi | 10.1016/j.trac.2008.06.004 10.1016/j.ijbiomac.2023.129178 10.1016/j.porgcoat.2021.106157 10.1093/nar/gkab957 10.3389/fmolb.2021.670792 10.1016/j.triboint.2023.108891 10.21203/rs.3.rs-2520455/v1 10.1007/s10965-023-03485-0 10.1111/cod.12074 10.1016/j.jinorgbio.2017.08.019 10.5530/jyp.2023.15.29 10.4314/tjpr.v20i9.3 10.17533/udea.vitae.17322 10.53879/id.59.04.13013 10.2174/1574893617666220404145517 10.1016/j.bioorg.2019.02.010 10.1084/jem.20211387 10.1016/j.jag.2023.103559 10.1186/s12903-023-03511-z 10.1007/s40199-018-0207-3 10.1016/j.engreg.2022.01.001 10.1038/s41579-021-00639-z 10.1080/00958972.2022.2142908 10.1016/j.jep.2014.05.042 10.1016/j.apsb.2019.09.003 10.1016/j.molstruc.2021.130533 10.3390/molecules22122223 10.1016/j.apsb.2022.05.024 10.1155/2015/912342 10.1016/j.ijpharm.2024.123815 10.3390/pharmaceutics15030931 10.1039/D1NJ01913A 10.1016/j.bmcl.2019.126817 10.1166/jnn.2015.11695 10.3892/ijmm.2017.2989 10.2174/138945012804545588 10.1007/s10854-020-03394-8 10.1016/j.scib.2020.09.019 10.1007/s11696-022-02242-9 10.32350/sir.72.04 10.1016/j.colsurfa.2022.129708 10.1007/s00384-020-03829-y 10.1016/j.msec.2021.112142 10.3322/caac.21763 10.4103/1319-3767.166206 10.1002/jbm.a.36506 10.1038/s41568-022-00496-9 10.1016/B978-0-323-46142-9.00029-3 10.1016/j.ejon.2021.101908 10.1016/j.trac.2022.116659 10.1016/j.chemphyslip.2021.105123 10.1002/slct.201904159 10.1080/09205063.2013.804758 10.1002/adhm.201900772 10.1016/j.biopha.2017.01.169 10.1016/j.msec.2021.112294 10.3390/molecules26216440 10.1016/j.fss.2024.108858 10.1016/B978-0-323-51254-1.00005-1 10.1186/s12645-023-00200-y 10.1177/15280837221121977 10.1137/18M1167863 10.1039/C4TB00015C 10.1021/acschembio.8b00306 10.1016/j.carbpol.2021.118482 |
ContentType | Journal Article |
Copyright | 2024 Wiley‐VHCA AG, Zurich, Switzerland 2024 Wiley‐VHCA AG, Zurich, Switzerland. |
Copyright_xml | – notice: 2024 Wiley‐VHCA AG, Zurich, Switzerland – notice: 2024 Wiley‐VHCA AG, Zurich, Switzerland. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7TM 8FD FR3 K9. M7N P64 7X8 |
DOI | 10.1002/cbdv.202301777 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Biotechnology Research Abstracts Nucleic Acids Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Biotechnology Research Abstracts Technology Research Database Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Biotechnology Research Abstracts MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1612-1880 |
EndPage | n/a |
ExternalDocumentID | 10_1002_cbdv_202301777 38373183 CBDV202301777 |
Genre | reviewArticle Journal Article Review |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1L6 1OC 29B 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACIWK ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ O66 O9- OIG P2P P2W P2X P4D PQQKQ Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SUPJJ SV3 UB1 V2E W8V W99 WBFHL WBKPD WIH WIK WJL WOHZO WQJ WRC WXSBR WYISQ XG1 XV2 ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7TM 8FD FR3 K9. M7N P64 7X8 |
ID | FETCH-LOGICAL-c3737-634e9f29352ce155dd4f1ad7849896584ac1301aa6373d29406cf165a67e0e8f3 |
IEDL.DBID | DR2 |
ISSN | 1612-1872 |
IngestDate | Sat Aug 17 05:33:11 EDT 2024 Fri Sep 13 08:11:10 EDT 2024 Fri Aug 23 04:45:32 EDT 2024 Tue Aug 27 13:46:53 EDT 2024 Sat Aug 24 00:57:32 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Nanomaterials Infection therapy Anticancer Lawsone |
Language | English |
License | 2024 Wiley‐VHCA AG, Zurich, Switzerland. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3737-634e9f29352ce155dd4f1ad7849896584ac1301aa6373d29406cf165a67e0e8f3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
PMID | 38373183 |
PQID | 3039679803 |
PQPubID | 986337 |
PageCount | 14 |
ParticipantIDs | proquest_miscellaneous_2928856466 proquest_journals_3039679803 crossref_primary_10_1002_cbdv_202301777 pubmed_primary_38373183 wiley_primary_10_1002_cbdv_202301777_CBDV202301777 |
PublicationCentury | 2000 |
PublicationDate | April 2024 2024-Apr 2024-04-00 20240401 |
PublicationDateYYYYMMDD | 2024-04-01 |
PublicationDate_xml | – month: 04 year: 2024 text: April 2024 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Weinheim |
PublicationTitle | Chemistry & biodiversity |
PublicationTitleAlternate | Chem Biodivers |
PublicationYear | 2024 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2022; 651 2017; 22(12) 2022; 12(10) 2008; 27(8) 2012; 2012 2021; 126 2021; 128 2023; 188 2017; 89 2013; 24(16) 2021; 20(9) 2023; 73(1) 2022; 219(4) 2022; 75(19-24) 2024 2022; 22(10) 2014; 2(1, pp. 1–81, Serial No. 2) 2015; 15(12) 2021; 1240 2021; 36 2014; 155(1) 2023; 14(1) 2023; 15(2) 2020; 65(24) 2021; 239 2021; 272 2021; 153 2013; 69(1) 2017; 40(1) 2021; 8 2022; 153 2023; 7(2) 2023; 30(3) 2020; 10(2) 2021; 2 2023; 15(3) 2022; 17(5) 2022; 50(D1) 2018; 13(8) 2023; 125 2020; 30(2) 2017; 176 2018; 4(1) 2021; 51 2018; 40(6) 2018; 26 2018; 106(12) 2022; 76(8) 2018; 78(4) 2023 2020; 31 2019; 85 2024; 259 2014; 2(21) 2022; 59(4) 2021; 45(32) 2012; 13(14) 2015; 2015 2014; 21(3) 2022; 52 2022; 20(4) 2024; 652 2023; 23(1) 2020; 5(9) 2021; 26(21) 2020; 9(9) 2015; 21(5) e_1_2_7_3_1 Francis S. M. (e_1_2_7_22_1) 2022; 59 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_60_1 e_1_2_7_17_1 e_1_2_7_62_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_64_1 e_1_2_7_1_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_28_1 Wen L. (e_1_2_7_32_1) 2015; 21 Huang S. (e_1_2_7_35_1) 2023; 14 e_1_2_7_50_1 e_1_2_7_71_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_52_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_54_1 e_1_2_7_21_1 e_1_2_7_56_1 Ghafaripour H. (e_1_2_7_49_1) 2023 e_1_2_7_37_1 e_1_2_7_58_1 e_1_2_7_39_1 Li X. (e_1_2_7_68_1) 2012; 2012 e_1_2_7_6_1 e_1_2_7_4_1 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_61_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_63_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_65_1 Mahkam M. (e_1_2_7_5_1) 2014; 2 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_67_1 Wei S. (e_1_2_7_30_1) 2018; 40 e_1_2_7_69_1 e_1_2_7_27_1 e_1_2_7_29_1 Naeeni N. B. (e_1_2_7_48_1) 2023 Adeli-Sardou M. (e_1_2_7_66_1) 2018; 4 e_1_2_7_72_1 e_1_2_7_51_1 e_1_2_7_70_1 e_1_2_7_53_1 e_1_2_7_24_1 e_1_2_7_55_1 e_1_2_7_34_1 e_1_2_7_57_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_59_1 e_1_2_7_38_1 |
References_xml | – volume: 21(3) start-page: 248 year: 2014 end-page: 258 publication-title: Vitae – volume: 239 year: 2021 publication-title: Chem. Phys. Lipids – volume: 52 year: 2022 publication-title: J. Ind. Text. – volume: 259 year: 2024 publication-title: Int. J. Biol. Macromol. – volume: 17(5) start-page: 473 year: 2022 end-page: 482 publication-title: Curr. Bioinf. – volume: 65(24) start-page: 2050 year: 2020 end-page: 2052 publication-title: Sci. Bull. – volume: 153 year: 2022 publication-title: TrAC Trends Anal. Chem. – volume: 30(2) year: 2020 publication-title: Bioorg. Med. Chem. Lett. – volume: 20(9) start-page: 1791 year: 2021 end-page: 1799 publication-title: Trop. J. Pharm. Res. – start-page: 1 year: 2023 end-page: 13 publication-title: Polym. Bull. – volume: 2012 start-page: 6 year: 2012 end-page: 6 publication-title: J. Nanomater. – volume: 2(1, pp. 1–81, Serial No. 2) start-page: 34 year: 2014 end-page: 38 publication-title: Iranian chemical communication – volume: 8 year: 2021 publication-title: Front. Mol. Biosci. – volume: 15(2) start-page: 201 year: 2023 end-page: 211 publication-title: J. Young Pharm. – volume: 89 start-page: 152 year: 2017 end-page: 161 publication-title: Biomed. Pharmacother. – volume: 15(3) start-page: 931 year: 2023 publication-title: Pharmaceutica – volume: 23(1) start-page: 840 year: 2023 publication-title: BMC Oral Health – volume: 2015 year: 2015 publication-title: J. Chem. – volume: 22(12) start-page: 2223 year: 2017 publication-title: Molecules – volume: 219(4) year: 2022 publication-title: J. Exp. Med. – volume: 188 year: 2023 publication-title: Tribol. Int. – volume: 75(19-24) start-page: 2509 year: 2022 end-page: 2532 publication-title: J. Coord. Chem. – volume: 652 year: 2024 publication-title: Int. J. Pharm. – volume: 5(9) start-page: 2710 year: 2020 end-page: 2718 publication-title: ChemistrySelect – volume: 73(1) start-page: 17 year: 2023 end-page: 48 publication-title: Ca-Cancer J. Clin. – volume: 69(1) start-page: 1 year: 2013 end-page: 25 publication-title: Contact Dermatitis – volume: 40(6) start-page: 3213 year: 2018 end-page: 3222 publication-title: Oncol. Rep. – volume: 24(16) start-page: 1815 year: 2013 end-page: 1830 publication-title: J. Biomater. Sci. Polym. Ed. – volume: 153 year: 2021 publication-title: Prog. Org. Coat. – volume: 36 start-page: 1007 year: 2021 end-page: 1016 publication-title: International Journal of Colorectal Disease – volume: 30(3) start-page: 108 year: 2023 publication-title: J. Polym. Res. – volume: 45(32) start-page: 14589 year: 2021 end-page: 14597 publication-title: New J. Chem. – volume: 2(21) start-page: 3190 year: 2014 end-page: 3195 publication-title: J. Mater. Chem. B – year: 2023 publication-title: IET Nanobiotechnol. – volume: 20(4) start-page: 193 year: 2022 end-page: 205 publication-title: Nat. Rev. Microbiol. – year: 2024 publication-title: Fuzzy Sets and Systems – volume: 176 start-page: 66 year: 2017 end-page: 76 publication-title: J. Inorg. Biochem. – volume: 128 year: 2021 publication-title: Mater. Sci. Eng. C – volume: 13(8) start-page: 1950 year: 2018 end-page: 1957 publication-title: ACS Chem. Biol. – volume: 125 year: 2023 publication-title: International Journal of Applied Earth Observation and Geoinformation – volume: 14(1) start-page: 1 year: 2023 end-page: 15 publication-title: Cancer Nanotechnology – volume: 126 year: 2021 publication-title: Mater. Sci. Eng. C – volume: 51 year: 2021 publication-title: European Journal of Oncology Nursing – volume: 26(21) start-page: 6440 year: 2021 publication-title: Molecules – volume: 78(4) start-page: 2129 year: 2018 end-page: 2153 publication-title: SIAM J. Appl. Math. – volume: 31 start-page: 8589 year: 2020 end-page: 8596 publication-title: Journal of Materials Science, Materials in Electronics – volume: 651 year: 2022 publication-title: Colloids Surf. A – volume: 10(2) start-page: 313 year: 2020 end-page: 326 publication-title: Acta Pharm. Sin. B – volume: 15(12) start-page: 10141 year: 2015 end-page: 10148 publication-title: J. Nanosci. Nanotechnol. – volume: 27(8) start-page: 672 year: 2008 end-page: 683 publication-title: TrAC Trends Anal. Chem. – volume: 22(10) start-page: 550 year: 2022 end-page: 556 publication-title: Nat. Rev. Cancer – volume: 50(D1) start-page: D1123 year: 2022 end-page: D1130 publication-title: Nucleic Acids Res. – volume: 21(5) start-page: 313 year: 2015 publication-title: Saudi Journal of Gastroenterology, Official Journal of the Saudi Gastroenterology Association – volume: 4(1) start-page: 46 year: 2018 end-page: 57 publication-title: Biomacromolecular Journal – volume: 2 start-page: 219 year: 2021 end-page: 226 publication-title: Engineered Regeneration – volume: 9(9) year: 2020 publication-title: Adv. Healthcare Mater. – volume: 155(1) start-page: 80 year: 2014 end-page: 103 publication-title: J. Ethnopharmacol. – volume: 272 year: 2021 publication-title: Carbohydr. Polym. – volume: 106(12) start-page: 3111 year: 2018 end-page: 3122 publication-title: J. Biomed. Mater. Res. Part A – volume: 40(1) start-page: 235 year: 2017 end-page: 242 publication-title: Int. J. Mol. Med. – volume: 76(8) start-page: 5043 year: 2022 end-page: 5050 publication-title: Chem. Pap. – volume: 59(4) year: 2022 publication-title: Indian Drugs – volume: 12(10) start-page: 3877 year: 2022 end-page: 3890 publication-title: Acta Pharm. Sin. B – volume: 1240 year: 2021 publication-title: J. Mol. Struct. – volume: 7(2) start-page: 71 year: 2023 end-page: 80 publication-title: Scientific Inquiry and Review – volume: 26 start-page: 11 year: 2018 end-page: 17 publication-title: Daru J. Fac. Pharm. Tehran Univ. Med. Sci. – volume: 85 start-page: 455 year: 2019 end-page: 468 publication-title: Bioorg. Chem. – volume: 13(14) start-page: 1777 year: 2012 end-page: 1798 publication-title: Curr. Drug Targets – ident: e_1_2_7_72_1 doi: 10.1016/j.trac.2008.06.004 – ident: e_1_2_7_56_1 doi: 10.1016/j.ijbiomac.2023.129178 – ident: e_1_2_7_67_1 doi: 10.1016/j.porgcoat.2021.106157 – ident: e_1_2_7_39_1 doi: 10.1093/nar/gkab957 – ident: e_1_2_7_46_1 doi: 10.3389/fmolb.2021.670792 – volume: 2 start-page: 34 year: 2014 ident: e_1_2_7_5_1 publication-title: Iranian chemical communication contributor: fullname: Mahkam M. – ident: e_1_2_7_29_1 doi: 10.1016/j.triboint.2023.108891 – ident: e_1_2_7_21_1 doi: 10.21203/rs.3.rs-2520455/v1 – ident: e_1_2_7_63_1 doi: 10.1007/s10965-023-03485-0 – ident: e_1_2_7_71_1 doi: 10.1111/cod.12074 – ident: e_1_2_7_23_1 doi: 10.1016/j.jinorgbio.2017.08.019 – start-page: 1 year: 2023 ident: e_1_2_7_48_1 publication-title: Polym. Bull. contributor: fullname: Naeeni N. B. – ident: e_1_2_7_18_1 doi: 10.5530/jyp.2023.15.29 – ident: e_1_2_7_44_1 doi: 10.4314/tjpr.v20i9.3 – ident: e_1_2_7_7_1 doi: 10.17533/udea.vitae.17322 – volume: 59 year: 2022 ident: e_1_2_7_22_1 publication-title: Indian Drugs doi: 10.53879/id.59.04.13013 contributor: fullname: Francis S. M. – ident: e_1_2_7_38_1 doi: 10.2174/1574893617666220404145517 – volume: 2012 start-page: 6 year: 2012 ident: e_1_2_7_68_1 publication-title: J. Nanomater. contributor: fullname: Li X. – ident: e_1_2_7_15_1 doi: 10.1016/j.bioorg.2019.02.010 – ident: e_1_2_7_12_1 doi: 10.1084/jem.20211387 – ident: e_1_2_7_33_1 doi: 10.1016/j.jag.2023.103559 – ident: e_1_2_7_55_1 doi: 10.1186/s12903-023-03511-z – ident: e_1_2_7_51_1 doi: 10.1007/s40199-018-0207-3 – ident: e_1_2_7_53_1 doi: 10.1016/j.engreg.2022.01.001 – ident: e_1_2_7_11_1 doi: 10.1038/s41579-021-00639-z – ident: e_1_2_7_20_1 doi: 10.1080/00958972.2022.2142908 – ident: e_1_2_7_19_1 doi: 10.1016/j.jep.2014.05.042 – ident: e_1_2_7_28_1 doi: 10.1016/j.apsb.2019.09.003 – ident: e_1_2_7_45_1 doi: 10.1016/j.molstruc.2021.130533 – ident: e_1_2_7_13_1 doi: 10.3390/molecules22122223 – ident: e_1_2_7_34_1 doi: 10.1016/j.apsb.2022.05.024 – ident: e_1_2_7_59_1 doi: 10.1155/2015/912342 – ident: e_1_2_7_54_1 doi: 10.1016/j.ijpharm.2024.123815 – ident: e_1_2_7_40_1 doi: 10.3390/pharmaceutics15030931 – ident: e_1_2_7_42_1 doi: 10.1039/D1NJ01913A – ident: e_1_2_7_10_1 doi: 10.1016/j.bmcl.2019.126817 – ident: e_1_2_7_4_1 doi: 10.1166/jnn.2015.11695 – ident: e_1_2_7_31_1 doi: 10.3892/ijmm.2017.2989 – ident: e_1_2_7_17_1 doi: 10.2174/138945012804545588 – ident: e_1_2_7_52_1 doi: 10.1007/s10854-020-03394-8 – ident: e_1_2_7_3_1 doi: 10.1016/j.scib.2020.09.019 – ident: e_1_2_7_62_1 doi: 10.1007/s11696-022-02242-9 – ident: e_1_2_7_16_1 doi: 10.32350/sir.72.04 – ident: e_1_2_7_2_1 doi: 10.1016/j.colsurfa.2022.129708 – ident: e_1_2_7_36_1 doi: 10.1007/s00384-020-03829-y – ident: e_1_2_7_41_1 doi: 10.1016/j.msec.2021.112142 – ident: e_1_2_7_8_1 doi: 10.3322/caac.21763 – ident: e_1_2_7_14_1 – volume: 21 start-page: 313 year: 2015 ident: e_1_2_7_32_1 publication-title: Saudi Journal of Gastroenterology, Official Journal of the Saudi Gastroenterology Association doi: 10.4103/1319-3767.166206 contributor: fullname: Wen L. – ident: e_1_2_7_65_1 doi: 10.1002/jbm.a.36506 – ident: e_1_2_7_9_1 doi: 10.1038/s41568-022-00496-9 – ident: e_1_2_7_69_1 doi: 10.1016/B978-0-323-46142-9.00029-3 – ident: e_1_2_7_43_1 doi: 10.1016/j.ejon.2021.101908 – ident: e_1_2_7_1_1 doi: 10.1016/j.trac.2022.116659 – ident: e_1_2_7_47_1 doi: 10.1016/j.chemphyslip.2021.105123 – ident: e_1_2_7_57_1 doi: 10.1002/slct.201904159 – ident: e_1_2_7_60_1 doi: 10.1080/09205063.2013.804758 – ident: e_1_2_7_37_1 doi: 10.1002/adhm.201900772 – year: 2023 ident: e_1_2_7_49_1 publication-title: IET Nanobiotechnol. contributor: fullname: Ghafaripour H. – ident: e_1_2_7_24_1 doi: 10.1016/j.biopha.2017.01.169 – volume: 40 start-page: 3213 year: 2018 ident: e_1_2_7_30_1 publication-title: Oncol. Rep. contributor: fullname: Wei S. – ident: e_1_2_7_61_1 doi: 10.1016/j.msec.2021.112294 – ident: e_1_2_7_64_1 doi: 10.3390/molecules26216440 – ident: e_1_2_7_27_1 doi: 10.1016/j.fss.2024.108858 – ident: e_1_2_7_70_1 doi: 10.1016/B978-0-323-51254-1.00005-1 – volume: 14 start-page: 1 year: 2023 ident: e_1_2_7_35_1 publication-title: Cancer Nanotechnology doi: 10.1186/s12645-023-00200-y contributor: fullname: Huang S. – ident: e_1_2_7_6_1 doi: 10.1177/15280837221121977 – volume: 4 start-page: 46 year: 2018 ident: e_1_2_7_66_1 publication-title: Biomacromolecular Journal contributor: fullname: Adeli-Sardou M. – ident: e_1_2_7_26_1 doi: 10.1137/18M1167863 – ident: e_1_2_7_50_1 doi: 10.1039/C4TB00015C – ident: e_1_2_7_25_1 doi: 10.1021/acschembio.8b00306 – ident: e_1_2_7_58_1 doi: 10.1016/j.carbpol.2021.118482 |
SSID | ssj0028808 |
Score | 2.4064307 |
SecondaryResourceType | review_article |
Snippet | Lawsone, a naturally occurring compound found in henna, has been used in traditional medicine for centuries due to its diverse biological activities. In recent... Abstract Lawsone, a naturally occurring compound found in henna, has been used in traditional medicine for centuries due to its diverse biological activities.... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | e202301777 |
SubjectTerms | Anticancer Anticancer properties Antimicrobial activity Apoptosis Cancer Cell proliferation Clinical trials Communicable Diseases Disease Management Effectiveness Humans Infection therapy Infectious diseases Lawsone Medical research Medical treatment Nanomaterials Nanoparticles Naphthoquinones - chemistry Neoplasms - drug therapy Pathogens Physicochemical processes Physicochemical properties Precision medicine Proliferation |
Title | Exploring the Therapeutic Potential of Lawsone and Nanoparticles in Cancer and Infectious Disease Management |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcbdv.202301777 https://www.ncbi.nlm.nih.gov/pubmed/38373183 https://www.proquest.com/docview/3039679803/abstract/ https://search.proquest.com/docview/2928856466 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED9EEHzx-6M6JYLgU7c1TdP2UTeHioiIyt5KmiYgSif7EPSv967tOqcPgr61hNAkd5f7pXf3C8Ax6q2NlOBuW3HjilD5bhqlgWukH_p4JiIGcsq2uJEXD-KqH_S_VPGX_BD1DzeyjGK_JgNX6ag1Iw3VafbWpMu_UadCKicnNj1CRXc1fxRH5Sxq4dCNu14U8ilrY5u35rvPe6UfUHMeuRaup7cKajroMuPkuTkZp0398Y3P8T-zWoOVCpey01KR1mHB5BuwVN5U-b4JL3WuHkPEyO5nVVvsdjCmjCPsPLDsugjCGqbyjOHGjSfyKvGOPeWsQxo2LNouqxywyYh1yxARmyXibMFD7_y-c-FWFzW4GiUautIXJrYIHAKuDQKULBPWU1kYiTgichmhNLpKTylSgIzHCCK09WSgZGjaJrL-NizmOLhdYFzjvC0XeGxNhRKBimSmEKOm2vrW87QDJ1NBJa8lH0dSMi_zhNYuqdfOgcZUjklll6MEHXZMcae278BR3YwWRWESlRucdsJj1JtACikd2CnlX3-KzvO0CzrACyn-Moakc9Z9rN_2_tJpH5bxuUoWasDieDgxB4iDxulhoeufrdX9dQ |
link.rule.ids | 315,786,790,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFH64IHpxX-oaQfDUcZqmaXvUUZnRcRAZxVtI0wREqaIzgv56X7oNowdBj20JzfK9vO8lX14ADhC3JpKMuk1JtctC6btJlASu5n7oY0xkM5BbtUWPt2_ZxX1QqQntWZgiP0S94GYtI5-vrYHbBemjUdZQlaTvDXv7N4IqDCdhGm0-yKOqmzqDFEV45qfh0JG7XhTSKm9jkx6Nlx_3Sz_I5jh3zZ3P-QIkVbULzcljYzhIGurzW0bHf7VrEeZLakqOCywtwYTOlmGmuKzyYwWearkeQdJI-qODW-T6eWBFR1j42ZBuvg-ricxSgnM3BuWl9o48ZKRlQfaaf-uUMrDhGzktdonISIuzCrfnZ_1W2y3vanAVDmrocp_p2CB3CKjSyFHSlBlPpmHE4sjml2FSobf0pLQYSGmMPEIZjweSh7qpI-OvwVSGldsAQhW221CGkWvCJAtkxFOJNDVRxjeepxw4rEZKvBQpOUSRfJkK23ei7jsHtquBFKVpvgn02bHdemr6DuzXn9Go7E6JzDQ2W9AYgRNwxrkD6wUA6l_ZkN5OhA7QfBh_qYNonZze1U-bfym0B7Pt_lVXdDu9yy2Yw_eldmgbpgavQ72DtGiQ7ObA_wKhsQGm |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB58oHjx_ajPCIKn7rZpmrZH3XVxdRERFW8hTRMQpYruCvrrnbTdrqsHQY9tCE0y32S-NJMvAAeIWxNLRl1PUu2ySAZuGqehq3kQBbgmsgrkNtvigp_esLO78O7LKf5SH6L-4WY9o5ivrYM_Z6Y5Eg1VafbWsJd_I6aiaBKmGQ-oxXX7qhaQoojO4jAcxnHXjyM6lG30aHO8_nhY-sE1x6lrEXs6CyCHrS5TTh4ag37aUB_fBB3_061FmK-IKTkqkbQEEzpfhpnyqsr3FXisk_UIUkZyPTq2RS6f-jblCCs_GdIrdmE1kXlGcObGJXmVeUfuc9KyEHspyrpVEtjglbTLPSIyysRZhZvOyXXr1K1uanAVmjRyecB0YpA5hFRpZChZxowvsyhmSWzVZZhUGCt9KS0CMpogi1DG56HkkfZ0bII1mMqxcRtAqMJ-G8pw3ZoyyUIZ80wiSU2VCYzvKwcOh4YSz6Ughyill6mwYyfqsXNge2hHUTnmq8CIndiNJy9wYL8uRpey-yQy19htQRPETcgZ5w6sl_avP2UX9HYadIAWVvylDaJ13L6tnzb_UmkPZi_bHdHrXpxvwRy-rhKHtmGq_zLQO8iJ-uluAftPk9EAVQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploring+the+Therapeutic+Potential+of+Lawsone+and+Nanoparticles+in+Cancer+and+Infectious+Disease+Management&rft.jtitle=Chemistry+%26+biodiversity&rft.au=Kamil+Zaidan%2C+Haider&rft.au=Jasim+Al%E2%80%90Khafaji%2C+Hanadi+Had&rft.au=Al%E2%80%90dolaimy%2C+F.&rft.au=Abed+Hussein%2C+Shaymaa&rft.date=2024-04-01&rft.issn=1612-1872&rft.eissn=1612-1880&rft.volume=21&rft.issue=4&rft_id=info:doi/10.1002%2Fcbdv.202301777&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_cbdv_202301777 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1612-1872&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1612-1872&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1612-1872&client=summon |